Global Health Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 32,820,975 (50%) | — | ₹110,278 Cr |
| NII (HNI) | — | 9,846,293 (15%) | — | ₹33,084 Cr |
| Retail | — | 22,974,684 (35%) | — | ₹77,195 Cr |
| Σ Total | — | 65,641,952 (100%) | — | ₹2,205,570 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 44 | ₹14,784 |
| Retail (Max) | 13 | 572 | ₹192,192 |
| S-HNI (Min) | 14 | 616 | ₹206,976 |
| B-HNI (Min) | 67 | 2,948 | ₹990,528 |
Financial Statements Amount in Crore
| Metric | 31-Mar-20 | 30-Jun-20 | 31-Mar-21 |
|---|---|---|---|
| Revenue | 1,544 | 492 | 1,478 |
| Profit After Tax | 36 | 42 | 29 |
| Net Worth | 1,350 | 1,425 | 1,382 |
| Total Assets | 2,666 | 2,855 | 2,694 |
| Total Borrowing | 622 | 725 | 645 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Investment in two of our Subsidiaries, GHPPL and MHPL, in the form of debt or equity for repayment/prepayment of borrowings, in full or part, of such Subsidiaries – 375.00
- 2 General corporate purposes – 101.70
Company Overview
Global Health Limited is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India. The company has key specialities in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.
Global Health Limited have a network of four hospitals currently in operation (Gurugram, Indore, Ranchi and Lucknow) under the "Medanta" brand. The company established "The Medanta Institutional Tissue Repository" in 2017 to promote biomarker and other tissue-based research.
In Fiscals 2020, 2021 and 2022 and the three months ended June 30, 2021 and 2022, the company generated income from healthcare services of Rs. 14,805.71 million, Rs. 14,178.41 million, Rs. 21,003.95 million, Rs. 4,732.10 million and Rs. 5,960.89 226 million, respectively, and had EBITDA of Rs. 2,304.54 million, Rs. 2,228.52 million, Rs. 4,897.57 million, Rs. 1,057.69 million and Rs. 1,416.46 million, respectively.
As of June 30, 2022, the company provide healthcare services in over 30 medical specialities and engage over 1,300 doctors led by experienced department heads, spanning an area of 4.7 million sq. ft., the operational hospitals have 2,467 installed beds.
Global Health Limited's hospital at Gurugram was ranked as the best private hospital in India for three consecutive years in 2020, 2021 and 2022, and was the only Indian private hospital to be featured in the list of top 200 global hospitals in 2021 and was featured in the list of top 250 global hospitals in 2022 by Newsweek
Competitive Strengths:
- Leading tertiary and quaternary care provider in India, well recognised for clinical expertise in particular in dealing with complicated cases.
- Focus on Clinical Research and Academics.
- Large-scale hospitals with world-class infrastructure, high-end medical equipment, and technology.
- Track record of strong operational and financial performance.
- Focus on under-served areas with dense population and presence in top or capital cities of large states (NCR, Lucknow and Patna).
- Growth opportunities in existing facilities and diversification into new services, including digital health.
- Experienced senior management team with strong institutional shareholder support.